Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
findings showed in intestinal epithelial cells that PAR-2 activation leads to polarized IL-8 (show IL8 Proteins) secretion in accordance with the side of PAR-2 activation, apical or basolateral, but do not affect ubiquitin proteasome system; demonstrate that PAR-2 activation leads to an increased IL-8 (show IL8 Proteins) production and can affect proteasome system, particularly when PAR-2 activation was induced in the apical side
TF-induced microvessel stabilization is regulated via PAR2-SMAD3 (show SMAD3 Proteins) that is indispensable for the maintenance of vascular integrity.
PAR-2- and PAR-1 (show MARK2 Proteins)-mediated TNF-alpha (show TNF Proteins) release from monocytes suggests that these unique protease receptors are involved in the pathogenesis of inflammation.
Results indicate that chymotrypsin-like serine protease (show F2 Proteins) enhances soluble fms-like tyrosine kinase 1 (show FLT1 Proteins) production through protease-activated receptor-2 in trophoblast cells and thus plays an important additional role in preeclampsia pathogenesis.
crystal structures of PAR2 in complex with two distinct antagonists and a blocking antibody
PAR-2 plays an important role in the progression of ovarian clear cell carcinoma.
Data suggest activation of PAR2 via FVIIA/TF signaling activates PI3K (show PIK3CA Proteins)/AKT (show AKT1 Proteins) signaling, inactivates GSK3b signaling, leads to accumulation of beta-catenin (show CTNNB1 Proteins), and promotes tumor cell migration/invasion. (PAR2 = protease-activated receptor 2; FVIIA = coagulation factor VIIa; TF = tissue factor/thromboplastin (show F3 Proteins); PI3K (show PIK3CA Proteins) = phosphatidylinositol 3-kinase; AKT (show AKT1 Proteins) = proto-oncogene (show RAB1A Proteins) protein c-akt (show AKT1 Proteins); GSK3b = glycogen synthase kinase 3 beta)
PAR2 modulation was sufficient to induce islet cell transdifferentiation in the absence of beta-cells.
Studies provide increasing evidence that PAR2 plays a significant role in inflammatory diseases both in the periphery and in the CNS. There is a clear similarity between PAR2 expression and activation on cells of the immune system and those cell types that are proposed to play a role within the CNS, astrocytes and microglia. [review]
Results show that PAR2 in hepatic stellate cells plays a crucial role in promoting hepatocellular carcinoma growth presumably by mediating migration and secretion of pro-angiogenic and pro-mitotic factors.
thrombin (show F2 Proteins) has a role in diet-induced obesity through fibrin-driven inflammation
Our results are suggestive that PAR2 inhibition may play a role in the treatment of diseases with increased inflammatory responses in renal systems
PAR2/GSK3beta is a novel pathway that plays a critical role in the regulation of stem/progenitor cell survival and proliferation in normal colon crypts and colon cancer.
Enhanced FXa (show F10 Proteins) and PAR2 exacerbate DN and that both are promising targets for preventing diabetic nephropathy.
PAR2 is critically important in the pathogenesis of adenine-induced tubular injury
The levels of miR (show MLXIP Proteins)-223, miR (show MLXIP Proteins)-339 and miR (show MLXIP Proteins)-21, which are associated with platelet activation, were elevated in pooled mouse plasma exosomes before thrombosis and enriched in thrombin (show F2 Proteins)-stimulated platelet-derived exosomes in vitro.
Neutrophil elastase (show ELANE Proteins) induced acute inflammation and pain in knee joints of mice. These changes are PAR2-dependent and appear to involve activation of a p44 (show GTF2H4 Proteins)/42 MAPK (show MAPK1 Proteins) pathway. Blocking neutrophil elastase (show ELANE Proteins), PAR2 and p44 (show GTF2H4 Proteins)/42 MAPK (show MAPK1 Proteins) activity can reduce inflammation and pain, suggesting their utility as therapeutic targets.
Reductions in astrogliosis, inflammation and neuromotor recovery observed in protease Activated Receptor 2 knockout mice after spinal cord injury suggests that this receptor and its agonists represent new drug targets to foster neuromotor recovery.
Stimulation of PAR-2 activates Nf-kappaB (show NFKB1 Proteins) signaling, resulting in RelA (show NFkBP65 Proteins) nuclear translocation and enhanced expression of pro-inflammatory mRNAs in oral squamous cell carcinoma.
PAR1 and PAR2 regulate endothelial NO synthase phosphorylation and activity through G(12/13) and G(q), delineating the signaling pathways by which the proteases act on protease-activated receptors to modulate endothelial functions.
Coagulation factor II (thrombin) receptor-like 1 (F2RL1) is a member of the large family of 7-transmembrane-region receptors that couple to guanosine-nucleotide-binding proteins. F2RL1 is also a member of the protease-activated receptor family. It is activated by trypsin, but not by thrombin. It is activated by proteolytic cleavage of its extracellular amino terminus. The new amino terminus functions as a tethered ligand and activates the receptor. The F2RL1 gene contains two exons and is widely expressed in human tissues. The predicted protein sequence is 83% identical to the mouse receptor sequence.
Proteinase-activated receptor 2
, G-protein coupled receptor 11
, coagulation factor II receptor-like 1
, protease-activated receptor 2
, proteinase-activated receptor 2
, thrombin receptor-like 1
, Protease-activated receptor-2
, proteinase-activated receptor-2
, Proteinase-activated receptor-2 G protein-coupled receptor 11
, Proteinase-activated receptor-2, G protein-coupled receptor 11